FDA Warns of Increased Danger with HIV Drug

Courtesy MedPage Today Infectious Disease  Sat, 08/29/2009 - 15:10

WASHINGTON (MedPage Today) -- The FDA alerted healthcare professionals that the HIV medication etravirine (Intelence) may cause severe skin reactions, and the manufacturer has updated the drug's label accordingly.


 

More related items

ICAAC: New Drug Easier to Take than HIV Standard...
CHICAGO (MedPage Today) -- The recently approved HIV drug rilpivirine (Edurant) is easier to take for the first three months of therapy than the widely used efavirenz (Sustiva), a researcher...

Untreated HIV Patients Have New Drug Option (CME/CE)
(MedPage Today) -- The recently approved anti-HIV drug rilpivirine (Edurant) is a new option for people starting treatment for the virus, according to investigators on two randomized...

ACTHIV: Etravirine Better in Less Treated Patients...
DENVER (MedPage Today) -- An HIV drug approved for heavily pre-treated patients yields better outcomes for those with less treatment experience, a researcher reported here.

The Unwritten Rules of Friendship: Simple Strategies...
"Nobody likes me!" is a complaint that parents hear all too often, and few utterances make them feel more helpless. Now help is at hand: This practical and compassionate guidebook enables...

Burt's Bees Free Head to Toe Starter Kit


 

Post new comment

The content of this field is kept private and will not be shown publicly.
health-fitness.marc8.com